Sergey Yurasov

Insider Reports History

Entity
Individual
Location
C/O Immune Design Corp., 1616 Eastlake Ave. E., Suite 310, Seattle, WA
Signature
/s/ Brent Hatzis-Schoch, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sergey Yurasov:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Black Diamond Therapeutics, Inc. CHIEF MEDICAL OFFICER Common Stock 75K $188K $2.50 Jan 30, 2025 Direct
Black Diamond Therapeutics, Inc. CHIEF MEDICAL OFFICER Stock Option (Right to Buy) 200K Jan 30, 2025 Direct

Insider Reports Filed by Sergey Yurasov

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDTX Black Diamond Therapeutics, Inc. Jan 30, 2025 2 $0 4 Jan 31, 2025 CHIEF MEDICAL OFFICER
BDTX Black Diamond Therapeutics, Inc. Feb 14, 2024 1 $0 4 Feb 15, 2024 CHIEF MEDICAL OFFICER
BDTX Black Diamond Therapeutics, Inc. Feb 13, 2023 1 $0 4 Feb 15, 2023 CHIEF MEDICAL OFFICER
BDTX Black Diamond Therapeutics, Inc. Jun 10, 2022 0 $0 3 Jun 15, 2022 CHIEF MEDICAL OFFICER